Media Summary: Immunotherapeutic agents are increasingly becoming incorporated into clinical practice; however, there is still much to learn, ... Eric K. Singhi, MD, The University of Texas MD Anderson In this educational video, Dr. Kellie Smith—a leading researcher at Johns Hopkins Medicine—explains how

Transforming Outcomes In Advanced Lung Cancer Immunotherapy In Unselected Patients - Detailed Analysis & Overview

Immunotherapeutic agents are increasingly becoming incorporated into clinical practice; however, there is still much to learn, ... Eric K. Singhi, MD, The University of Texas MD Anderson In this educational video, Dr. Kellie Smith—a leading researcher at Johns Hopkins Medicine—explains how Advances in how the immune system can be harnessed to fight cancer offer new hope to Dr. Greg Riely from Memorial Sloan-Kettering NCI's Dr. Shakun Malik, head of thoracic oncology therapeutics, and Janet Freeman-Daily,

We are excited to bring new and updated information to share through our Solange Peters, MD, PhD, and Suresh Senan, MRCP, FRCR, PhD, discuss emerging combination approaches for treating ... Chair, Jamie E. Chaft, MD, and Jonathan D. Spicer, MD, PhD, FRCSC, discuss NSCLC in this CME/MOC/CC/NCPD activity titled ... Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve Dr. Jack West reviews data from ESMO 2017 & the NEJM paper on the PACIFIC trial of durvalumab vs. placebo as consolidation ... Rapid advances are being made with increasing investigation into the use of

Chair and Presenter, Jonathan W. Goldman, MD, Ticiana A. Leal, MD, and Taofeek K. Owonikoko, MD, PhD, discuss small cell ... Hello and thank you for joining this Enclave peer exchange titled immuno oncology in

Photo Gallery

Transforming outcomes in advanced lung cancer: immunotherapy in unselected patients
Immunotherapy Advances Transform Small Cell Lung Cancer Care
Clinical outcomes of immunotherapy after radiographic progression in advanced NSCLC
How Immunotherapy Is Changing Lung Cancer Treatment
Immunotherapy: New Hope for Patients with Advanced Lung Cancer
What is the Role of Immunotherapy for Patients with Advanced NSCLC and a Driver Mutation?
A Changing Treatment Landscape in Advanced Lung Cancer
Lung Cancer Clinical Trials: Advances in Immunotherapy
Immunotherapy for Patients with Driver Mutation - Lung Cancer Video Library
Emerging Immunotherapy Options for Metastatic NSCLC
Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer
Clinical Trial Spotlight: Can Epigenetic Priming Improve Efficacy of Immunotherapy in NSCLC?
Sponsored
Sponsored
View Detailed Profile
Transforming outcomes in advanced lung cancer: immunotherapy in unselected patients

Transforming outcomes in advanced lung cancer: immunotherapy in unselected patients

Immunotherapeutic agents are increasingly becoming incorporated into clinical practice; however, there is still much to learn, ...

Immunotherapy Advances Transform Small Cell Lung Cancer Care

Immunotherapy Advances Transform Small Cell Lung Cancer Care

Immunotherapy

Sponsored
Clinical outcomes of immunotherapy after radiographic progression in advanced NSCLC

Clinical outcomes of immunotherapy after radiographic progression in advanced NSCLC

Eric K. Singhi, MD, The University of Texas MD Anderson

How Immunotherapy Is Changing Lung Cancer Treatment

How Immunotherapy Is Changing Lung Cancer Treatment

In this educational video, Dr. Kellie Smith—a leading researcher at Johns Hopkins Medicine—explains how

Immunotherapy: New Hope for Patients with Advanced Lung Cancer

Immunotherapy: New Hope for Patients with Advanced Lung Cancer

Advances in how the immune system can be harnessed to fight cancer offer new hope to

Sponsored
What is the Role of Immunotherapy for Patients with Advanced NSCLC and a Driver Mutation?

What is the Role of Immunotherapy for Patients with Advanced NSCLC and a Driver Mutation?

Dr. Greg Riely from Memorial Sloan-Kettering

A Changing Treatment Landscape in Advanced Lung Cancer

A Changing Treatment Landscape in Advanced Lung Cancer

In

Lung Cancer Clinical Trials: Advances in Immunotherapy

Lung Cancer Clinical Trials: Advances in Immunotherapy

NCI's Dr. Shakun Malik, head of thoracic oncology therapeutics, and Janet Freeman-Daily,

Immunotherapy for Patients with Driver Mutation - Lung Cancer Video Library

Immunotherapy for Patients with Driver Mutation - Lung Cancer Video Library

We are excited to bring new and updated information to share through our

Emerging Immunotherapy Options for Metastatic NSCLC

Emerging Immunotherapy Options for Metastatic NSCLC

Solange Peters, MD, PhD, and Suresh Senan, MRCP, FRCR, PhD, discuss emerging combination approaches for treating ...

Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer

Marking New Milestones With Immunotherapy in Locally Advanced and Early Lung Cancer

Chair, Jamie E. Chaft, MD, and Jonathan D. Spicer, MD, PhD, FRCSC, discuss NSCLC in this CME/MOC/CC/NCPD activity titled ...

Clinical Trial Spotlight: Can Epigenetic Priming Improve Efficacy of Immunotherapy in NSCLC?

Clinical Trial Spotlight: Can Epigenetic Priming Improve Efficacy of Immunotherapy in NSCLC?

Dr. Jack West reviews the concept of epigenetics, epigenetic priming, and whether oral azacytidine can improve

Personalized Medicine: Transforming Lung Cancer Treatment

Personalized Medicine: Transforming Lung Cancer Treatment

For many years nearly all

Immunotherapy in Stage III NSCLC: Practice-Changing Results of PACIFIC Trial (BMIC-006)

Immunotherapy in Stage III NSCLC: Practice-Changing Results of PACIFIC Trial (BMIC-006)

Dr. Jack West reviews data from ESMO 2017 & the NEJM paper on the PACIFIC trial of durvalumab vs. placebo as consolidation ...

Advances in perioperative immunotherapy in lung cancer

Advances in perioperative immunotherapy in lung cancer

Rapid advances are being made with increasing investigation into the use of

Advancements in diagnosis and treatment of lung cancer improving patient outcomes

Advancements in diagnosis and treatment of lung cancer improving patient outcomes

Lung cancer

Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?

Toward Better Outcomes in SCLC: Immunotherapy Has Changed the Game, but Where Do We Go Next?

Chair and Presenter, Jonathan W. Goldman, MD, Ticiana A. Leal, MD, and Taofeek K. Owonikoko, MD, PhD, discuss small cell ...

Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC

Transforming Care and Outcomes With Immunotherapy in Stage I-III Resectable NSCLC

This content has been

NSCLC Immunotherapy: Transformation of Upfront Therapy - O

NSCLC Immunotherapy: Transformation of Upfront Therapy - O

Hello and thank you for joining this Enclave peer exchange titled immuno oncology in

Lung Cancer Video Library 2020 - LEVY -  Immunotherapy Combinations for Advanced NSCLC

Lung Cancer Video Library 2020 - LEVY - Immunotherapy Combinations for Advanced NSCLC

For this new addition to the GRACE